Cargando…

Immune response after vaccination using inactivated vaccine for coronavirus disease 2019

Detalles Bibliográficos
Autores principales:	Sun, Ya, Kang, Haonan, Zhao, Yilan, Cui, Kai, Wu, Xuan, Huang, Shaohui, Liang, Chaofan, Wang, Wenqiang, Cao, Huixia, Zhang, Xiaoju, Shao, Fengmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278726/ https://www.ncbi.nlm.nih.gov/pubmed/37154087 http://dx.doi.org/10.1097/CM9.0000000000002707

Ejemplares similares

Does the homologous booster with the inactivated coronavirus disease 2019 vaccine work for the omicron variant? Real-world evidence from Jilin, China
por: Guo, Jun, et al.
Publicado: (2023)

Split-dosing of coronavirus disease 2019 vaccines
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity
por: Bao, Pengtao, et al.
Publicado: (2023)

Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Mandatory vaccination in child daycare and its relevance to coronavirus disease 2019
por: den Exter, André
Publicado: (2021)

Reply: Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Heo, Sang Taek
Publicado: (2022)

Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
por: Wang, Ziqi, et al.
Publicado: (2022)

Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines: Not the usual suspects?
por: de Chaisemartin, Luc, et al.
Publicado: (2022)

Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine
por: Peng, Pai, et al.
Publicado: (2021)

Coronavirus disease 2019 vaccine for children in China: when to start? Mandatory or voluntary?
por: Liu, Fei, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID‐19) vaccination in patients with cirrhosis: Does it work?
por: Calleri, Alberto, et al.
Publicado: (2022)

Clinical Considerations During Breakthrough Coronavirus Disease 2019 Infections in Vaccinated Individuals With Autoimmunity
por: Rocco, Joseph M, et al.
Publicado: (2021)

Antibody response to coronavirus disease 2019 vaccines after allergic reaction to first dose: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Antibody Response to the Coronavirus Disease 2019 Ad26.COV2.S Vaccine Among Maintenance Dialysis Patients
por: Ficociello, Linda H., et al.
Publicado: (2022)

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
por: Lim, Wey Wen, et al.
Publicado: (2021)

Inactivated canine coronavirus vaccine
Publicado: (1986)

Bacillus Calmette-Guerin (BCG) Site Reaction after Coronavirus Disease 2019 (COVID-19) mRNA Vaccination
por: Günaydın, Sibel Doğan, et al.
Publicado: (2023)

SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients
por: Deng, Yao, et al.
Publicado: (2021)

Epitopes for a 2019-nCoV vaccine
por: Lucchese, Guglielmo
Publicado: (2020)

Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines
por: Zhao, Xin, et al.
Publicado: (2022)

Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021)

Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
por: Zuo, Fanglei, et al.
Publicado: (2023)

Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people
por: Rouco, Santiago Oviedo, et al.
Publicado: (2022)

Gut Microbiome Metabolism Drives the Resolution of Patients With Coronavirus Disease 2019
por: Zhang, Yu-Hang, et al.
Publicado: (2022)

Correspondence on “Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination”
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Famotidine and Mortality in Coronavirus Disease 2019
por: Sethia, Rahul, et al.
Publicado: (2021)

Asthma and prognosis of coronavirus disease 2019
por: Özdemir, Öner
Publicado: (2022)

Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019
por: Huang, Lan, et al.
Publicado: (2020)

MicroCLOTS pathophysiology in coronavirus disease 2019
por: Renzi, Samuele, et al.
Publicado: (2023)

A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
por: Yu, Haisheng, et al.
Publicado: (2023)

Disseminated herpes zoster following inactivated SARS-CoV-2 vaccine in a healthy old man
por: Zhang, Li-wen, et al.
Publicado: (2022)

Vaccination Did Not Prevent Severe Coronavirus Disease 2019 in an Outbreak Among Older Residents of a Nursing Home, B.1.617.2 Variant, July 2021( )
por: Buskermolen, Maaike, et al.
Publicado: (2022)

Aplastic anemia following the severe acute respiratory syndrome coronavirus‐2 vaccine
por: Babakhanlou, Rodrick, et al.
Publicado: (2022)

Cytokine levels and pathological characteristics of a patient with severe coronavirus disease 2019: a case report
por: Kang, Kai, et al.
Publicado: (2022)

Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection
por: Xiang, Tiandan, et al.
Publicado: (2021)

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies
por: Cheng, Lin, et al.
Publicado: (2021)

An in silico epitope-based peptide vaccine design against the 2019-nCoV
por: Durojaye, Olanrewaju Ayodeji, et al.
Publicado: (2020)

Effects of coronavirus disease 2019 (COVID-19), including its prevention and treatment, on the male reproductive system
por: Liu, Kai, et al.
Publicado: (2021)

Pneumothorax in 2019 novel coronavirus pneumonia needs to be recognized
por: Li, Wenya, et al.
Publicado: (2020)

Coronavirus disease 2019 presenting with conjunctivitis as the first symptom
por: Casalino, Giuseppe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q0ssn7po93s7h06285guuu220s